Sign in

NCT07453303Completed

Comprehensive Geriatric Assessment in Adults Aged 40 Years and Older Living With HIV

Prospective Comparative Evaluation of Frailty, Sarcopenia, Nutritional Status, Cognitive Function, and Functional Performance in Adults Aged 40 Years and Older Living With HIV and Age- and Sex-Matched Healthy Controls

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

People living with HIV are experiencing longer life expectancy due to effective antiretroviral therapy; however, they may develop age-related conditions earlier than the general population. This prospective observational study aims to evaluate frailty, sarcopenia, nutritional status, cognitive function, and functional performance in adults aged 40 years and older living with HIV and to compare them with age- and sex-matched healthy controls.

Status (registry)
Completed
Study type
Observational
Enrollment
103 (actual)
First submitted
2 Mar 2026
Start date
1 Apr 2026
Primary completion date
31 May 2026
Lead sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Diseases
HIV
NCT number
NCT07453303

What you commit to

  • Study type: Observational
  • Participants enrolled: 103
  • From 1 Apr 2026 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Acute infection or hospitalization within the previous 4 weeks

Other illness

  • Known active malignancy under treatment
  • Severe psychiatric disorder interfering with assessment
  • Severe cognitive impairment preventing participation

Who the study is looking for

  • Age ≥40 years
  • Confirmed diagnosis of HIV infection (HIV group)
  • Stable antiretroviral therapy for at least 6 months (HIV group)
  • HIV-negative status confirmed by medical history or testing (control group)
  • Ability to provide informed consent

Age in the registry: 40 years to 99 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Tekirdağ Dr. İsmail Fehmi Cumalıoğlu City Hospital
Coordinator of this site? Confirm its status
TekirdağTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.